Vanda Pharmaceuticals Inc...

NASDAQ: VNDA · Real-Time Price · USD
4.37
-0.06 (-1.35%)
At close: Aug 15, 2025, 3:59 PM
4.33
-0.92%
After-hours: Aug 15, 2025, 04:23 PM EDT

Vanda Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-66.94M -44.25M -18.9M -16.39M -10.93M -4.89M 2.51M 11.77M 14.9M 15.96M 6.28M 6.49M 10.99M 18.07M 33.15M 34.26M 32.44M 31.5M
Depreciation & Amortization
3.14M 7.89M 8.13M 7.32M 5.93M 4.56M 3.01M 2.52M 2.61M 2.7M 2.73M 2.78M 2.81M 2.83M 2.84M 2.85M 2.86M 2.86M
Stock-Based Compensation
10.94M 11.82M 12.43M 12.84M 13.01M 13.27M 14.04M 14.55M 15.27M 15.85M 16.28M 16.27M 16.33M 16.24M 15.37M 14.81M 14M 13.32M
Other Working Capital
-9.45M -9.16M 7.45M 4.81M 3.14M -3.77M 11.71M 14.09M 32.75M 37.96M -151K -5.37M -15.06M -10.55M 4.4M 5.03M 9.29M 6.42M
Other Non-Cash Items
17.76M -2.45M -4.38M -4.93M -5.33M -5.03M -4.72M -4.58M -3.22M -1.66M -507K 1.16M 2.67M 3.22M 3.37M 3.41M 3.33M 2.45M
Deferred Income Tax
-20.77M -14.03M -6.48M -12.05M -6.24M -3.55M -1.29M 6.62M 2.05M -1.27M 1.13M 2.03M 6.39M 10M 6.75M 7.83M 7.08M 6.47M
Change in Working Capital
-8.92M -15.45M -6.56M -4.46M -1.59M -15.81M -747K -4.92M 9.22M 28.16M 6.07M 20.45M 6.55M 8.7M 2.74M -6.25M -2.82M 5.27M
Operating Cash Flow
-64.8M -56.47M -15.76M -17.67M -5.14M -11.43M 12.8M 25.95M 40.84M 59.74M 31.98M 49.17M 45.73M 59.07M 64.21M 56.91M 56.89M 61.88M
Capital Expenditures
-1.11M -919K -490K -529K -392K -339K -383K -393K -517K -655K -679K -550K -392K -497K -552K -1.38M -1.64M -1.55M
Cash Acquisitions
n/a n/a -2.71M -103.37M -138.72M 52.12M 55.48M 80.45M 137.43M -39.01M -39.66M 36.02M 14.39M -12K -24K -241K -241K -241K
Purchase of Investments
-272.44M -332.1M -364.77M -327.35M -290.26M -425.57M -512.61M -461.94M -584.25M -433.17M -349.26M -450.22M -399.09M -406.54M -420.46M -397.7M -392.85M -398.28M
Sales Maturities Of Investments
318.23M 379.23M 352.06M 367.56M 353.61M 311.71M 601.6M 569.49M 634.82M 660.18M 399.86M 399.27M 353.17M 341.13M 344.32M 331.7M 295.85M 338.11M
Other Investing Acitivies
n/a -1.52M -4.23M 52.91M 88.26M -101.06M -99.01M -80.45M -137.43M 39.01M 50.6M -25.07M -20.04M -39.53M -50.46M -50.24M -81.24M -44.42M
Investing Cash Flow
44.68M 44.69M -17.43M -65.21M -41.94M -217.57M -12.06M 107.16M 50.05M 226.35M 49.92M -51.5M -46.31M -65.9M -76.7M -67.38M -98.64M -61.73M
Debt Repayment
-409K -409K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-915K -915K n/a n/a n/a n/a n/a 605K 609K 734K 734K 1.17M 1.54M 1.7M 3.55M 3.94M 3.69M 7M
Financial Cash Flow
-1.75M -1.32M n/a n/a n/a n/a n/a 605K 609K 734K 734K 1.17M 1.54M 1.7M 3.55M 3.94M 3.69M 7M
Net Cash Flow
8.84M -13.36M -33.51M -82.69M -47.08M -229.01M 792K 133.79M 91.76M 287.19M 82.91M -1.18M 920K -5.27M -9.02M -6.51M -38.06M 7.18M
Free Cash Flow
-65.91M -57.39M -16.25M -18.2M -5.53M -11.77M 12.42M 25.56M 40.32M 59.09M 31.3M 48.63M 45.34M 58.57M 63.66M 55.52M 55.25M 60.32M